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The role of estrogen receptor β in 
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expression of Female sexual 
Behavior in c57Bl/6J Mice
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Tsuda1, Naoko Yamaguchi3, Toshiro Sakamoto4 and Sonoko Ogawa1*
1 Laboratory of Behavioral Neuroendocrinology, University of Tsukuba, Tsukuba, Japan, 2 Laboratory of Molecular 
Neurosurgery, Department of Neurological Surgery, Weill Cornell Medical College, New York, NY, United States, 3 Department 
of Medicine, Aichi Medical University, Nagakute, Japan, 4 Department of Health Sciences, Kyoto Tachibana University,  
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17β-Estradiol (E2) regulates the expression of female sexual behavior by acting through 
estrogen receptor (ER) α and β. Previously, we have shown that ERβ knockout female 
mice maintain high level of lordosis expression on the day after behavioral estrus when 
wild-type mice show a clear decline of the behavior, suggesting ERβ may be involved in 
inhibitory regulation of lordosis. However, it is not identified yet in which brain region(s) 
ERβ may mediate an inhibitory action of E2. In this study, we have focused on the dorsal 
raphe nucleus (DRN) that expresses ERβ in higher density than ERα. We site specifi-
cally knocked down ERβ in the DRN in ovariectomized mice with virally mediated RNA 
interference method. All mice were tested weekly for a total of 3 weeks for their lordosis 
expression against a stud male in two consecutive days: day 1 with the hormonal con-
dition mimicking the day of behavioral estrus, and day 2 under the hormonal condition 
mimicking the day after behavioral estrus. We found that the level of lordosis expression 
in ERβ knockdown (βERKD) mice was not different from that of control mice on day 1. 
However, βERKD mice continuously showed elevated levels of lordosis behavior on day 
2 tests, whereas control mice showed a clear decline of the behavior on day 2. These 
results suggest that the expression of ERβ in the DRN may be involved in the inhibitory 
regulation of sexual behavior on the day after behavioral estrus in cycling female mice.
Keywords: adeno-associated virus-mediated rna interference, estrogen receptor β, estrogen receptor α, 
lordosis, dorsal raphe nucleus, estrogen, progesterone, serotonin
inTrODUcTiOn
The expression of female sexual behavior undergoes cyclic change during an estrus cycle. An ovarian 
hormone, 17β-estradiol (E2) plays an essential role in this cyclic regulation of the behavior. In rodents, 
lordosis, a stereotypical female sexual behavior is expressed at high levels only during the time around 
ovulation, the period called as “behavioral estrus” occurring subsequently to the exponential eleva-
tion of circulating E2. E2 is known to act through at least two receptor subtypes, estrogen receptor 
(ER) α and β. Studies using knockout mouse models have shown that the level of sexual behavioral 
expression is greatly reduced in ERα knockout (αERKO) females (1–3) whereas in the ERβ knock-
outs (βERKO), such alteration is not observed (4, 5). It has also been reported that the selective ERα 
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agonist, propyl-pyrazole triol facilitates female sexual behavior 
in ovariectomized female rat whereas the selective ERβ agonist, 
diarylpropionitrile (DPN) is unable to do so (6). Furthermore, 
Musatov et al. (7) demonstrated that the site-specific knockdown 
of ERα in the ventromedial nucleus of the hypothalamus (VMN) 
leads to a complete disappearance of female sexual behavior in 
mice. These studies collectively suggest that E2 action through 
ERα, particularly in the VMN, is necessary for normal display 
of female sexual behavior whereas ERβ may not be involved in 
facilitatory regulation of female sexual behavior by E2. However, 
close observation of gonadally intact βERKO mice has revealed 
an intriguing behavioral phenotype that the period of behavioral 
estrus may be extended in βERKO females (4). In these mice, 
the level of sexual receptivity was reported to stay high until the 
day after behavioral estrus when their respective wild-type (WT) 
mice show a clear decline of the behavior. In addition, except 
the day of behavioral estrus and the day after, βERKO females 
express very little receptive behavior similar to WT females (4). 
To replicate this finding in more hormonally controlled setting, 
we performed a preliminary experiment in ovariectomized 
βERKO females treated with exogenous ovarian steroids. We 
found that these females continuously showed elevated levels of 
lordosis expression 72 h after estradiol benzoate (EB) and 24 h 
after progesterone administration that mimic typical hormonal 
condition of the day after behavioral estrus (unpublished data). 
These findings collectively suggest that E2 is not only promoting 
sexual behavior in females during the behavioral estrus with ERα 
dependent mechanisms but also involved in active inhibition of 
lordosis expression on the day after behavioral estrus by acting 
through ERβ. To further test this hypothesis and elucidate pos-
sible neural mechanisms of ERβ-mediated inhibitory regulation 
of lordosis, we aimed to identify the responsible brain site(s) in 
this study.
The dorsal raphe nucleus (DRN) is one of the brain areas 
that possibly act inhibitory on the expression of female sexual 
behavior. Lesions of this area are reported to increase lordosis 
expression in both EB-treated ovariectomized female rat and 
EB-treated castrated male rat (8–11) whereas the electrical 
stimulation of the DRN can lead to marked and immediate 
suppression of lordosis in ovariectomized female rat hormonally 
primed with EB and progesterone (12). In addition to its possible 
inhibitory role in the regulation of female sexual behavior, the 
DRN is also known for high levels of ERβ expression that is about 
two-fold of that of ERα within the nucleus (13, 14). Thus, it is 
reasonable to hypothesize that the DRN may be the brain site 
responsible for ERβ-mediated inhibitory action of E2 in female 
sexual behavior. To test this hypothesis, we employed a virally 
mediated RNA interference method and examined the effects of 
site-specific knockdown of ERβ in the DRN on the expression of 
lordosis behavior.
MaTerials anD MeThODs
subjects
Adult C57BL/6J female mice originally purchased from a com-
mercial breeder (CLEA, Japan) and maintained in a breeding 
colony at the University of Tsukuba. All mice were housed under 
standard conditions (23 ± 2°C) with a 12:12-h light/dark cycle 
(lights off at 12:00). Food and water were provided ad  libitum. 
All procedures were approved by the Animal Care and Use 
Committee and the Recombinant DNA Use Committee at the 
University of Tsukuba and conducted strictly in accordance with 
the National Institutes of Health guidelines. All efforts were made 
to minimize the number of animals and their suffering.
Design of small hairpin (sh) rna for er β 
silencing
Adeno-associated virus (AAV) vectors expressing an shRNA 
against either the sequence specific for the ERβ gene (AAV-shERβ: 
5′-GATCCCCGCCACGAATCAGTGTACCAT CTTCCTGT
CAATGGTACACTGATTCGTGGCTTTTTTGGAAT-3′ and 
5′-CTA GATTCCAAAAAAGCCACGAATCAGTGTACCATTG
ACAGGAAGATGGTACACTGATTCGTGGCGGG-3′) or the 
sequence specific for luciferase (LUC) as control (AAV-shLUC: 
5′-GATCCCCCCGCTGGAGAGCAACT GCATCTTCCTGT
CAATGCAGTTGCTCTCCAGCGGTTTTTGGAAT-3′ and 
5′-CTA GATTCCAAAAACCGCTGGAGAGCAACTGCATTG
ACAGGAAGATGCAGTTGCTCTCCAGCGGGGG-3′) were 
used. The nucleotides specific for ERβ or LUC are underlined. 
These vectors also express enhanced green fluorescent protein 
(GFP) as a reporter to visually detect transduced neurons.
stereotaxic surgery
Adult female mice (11.4 ± 2.2 weeks old) were assigned to either 
vector treatment (i) AAV-shERβ [ERβ knockdown (βERKD)] 
or (ii) AAV-shLUC (Control). They were anesthetized with 
sodium pentobarbital (60  mg/kg) and placed in a stereotaxic 
frame. A 5 µl Hamilton syringe inclined at 25° was aimed at the 
DRN [anteroposterior, −4.96 mm, mediolateral, 0.00 mm; dors-
oventral, −3.40 mm] that was determined based on The Mouse 
Brain Stereotaxic Coordinates (15). Each mouse was injected 
with 0.5 µl of either AAV-shERβ or AAV-shLUC (1012 packaged 
genomic particles) using a micropump injector (World Precision 
Instruments Inc., USA). The injection lasted 5 min, and the nee-
dle was left in place for an additional 10 min following the end 
of infusion. Mice were then group housed with their littermates 
(4–5 mice/cage) until they were used for behavioral studies.
Ovariectomy and hormone Treatment
Two weeks after stereotaxic surgery, all mice were ovariectomized 
(OVX) under isoflurane inhalation anesthesia. Mice were then 
individually housed in plastic cages (19 cm × 29 cm × 19 cm). All 
female mice were hormonally treated with weekly subcutaneous 
injections of EB (5 μg/0.1 ml sesame oil) followed by progesterone 
(P; 250 μg/0.1 ml sesame oil) at 44–46 h later, to mimic hormonal 
conditions in cycling females.
sexual Behavior Test
Starting 1 week after OVX, all mice were weekly tested for sexual 
behavior against a sexually experienced male (gonadally intact 
ICR/Jcl) mouse in the males’ home cages on two consecutive 
days, for a total of six trials during 3 weeks. For each week, mice 
were first tested 4–5 h after P injection which mimic the day of 
behavioral estrous (day 1), then tested again 24 h later (day 2) 
FigUre 1 | Experimental paradigm.
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(Figure 1). Each test was performed during the dark phase (start-
ing 2–3 h after lights off) of the light/dark cycle under red light 
illumination. Each test lasted until females received 15 mounts 
or intromissions. Male intromissions were terminated (after 
about 8 thrusts) by the experimenter after female’s behavioral 
responses were scored. Lordosis quotient (LQ) was calculated by 
dividing the number of lordosis responses by 15, the number of 
mounts or intromissions. In addition, each lordosis posture was 
given a score of 1–3 depending on the degree of dorsiflexion of 
the vertebral column and behaviors. For calculation of Lordosis 
Quality Scores, only lordosis responses that were given a score 
between 1 and 3 were included and averaged in each mouse. 
Mice with no lordosis response were excluded from the analysis 
in each test.
Tissue Preparation for 
immunohistochemistry
Two weeks after the completion of behavioral testing, all mice 
were given subcutaneous injection of EB (5 μg/0.1  ml sesame 
oil). Forty-eight hours later, the time point matching the hor-
monal condition of day 1 tests, they were deeply anesthetized 
with a solution of 1:1 mixture of sodium pentobarbital (60 mg/
kg) and heparin (1,000 U/kg) and transcardially perfused with 
0.1 M phosphate-buffered saline (PBS; pH 7.2) followed by 4% 
paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB; pH 7.2). 
Brains were removed and post-fixed overnight at 4°C in 4% PFA 
in 0.1 M PB. They were then rinsed with 0.1 M PB and cryopro-
tected in 0.1 M PB containing 30% sucrose.
immunohistochemistry
Free-floating coronal sections (35  µm thickness) prepared on 
freezing microtome were split into four series (140  µm apart). 
One series of sections from each mouse was incubated in a rinse 
buffer, PBS-X (PBS and 0.2% Triton X-100), containing 1% 
hydrogen peroxide for 20 min to inhibit endogenous peroxidase 
activity, and then blocked in an incubation buffer (3% skim 
milk and 3% bovine serum albumin in PBS-X) for 2 h at room 
temperature. After the blocking process, they were incubated 
in a goat polyclonal anti-GFP antiserum (1:5,000; ab6673, 
Abcam) dissolved in the incubation buffer overnight at 4°C. 
Sections were then treated with a 1:250 dilution of biotinylated 
rabbit anti-goat secondary antibody (Vector Laboratories) in the 
incubation buffer for 2 h at room temperature, followed by 1 h 
incubation with avidin-biotin complex (Vectastain ABC Elite 
kit, Vector Laboratories) in TBS. After the completion of anti-
serum reaction procedures, sections were visualized with 0.02% 
diaminobenzidine and 0.003% hydrogen peroxide in TBS. A few 
sections from each group were also processed for immunohisto-
chemical staining for ERβ. They were incubated in a rinse buffer, 
PBS-X, containing 1% hydrogen peroxide for 20 min, and then 
blocked in an incubation buffer (5% bovine serum albumin in 
PBS-X) for 2 h at room temperature. After the blocking process, 
they were incubated in a goat polyclonal anti-ERβ antiserum 
(1:1,000; Z8P, lot 10766190, Zymed Laboratories) dissolved in the 
incubation buffer for three days at 4°C. Sections were then treated 
with a1:250 dilution of biotinylated goat anti-rabbit secondary 
antibody (Vector Laboratories) in the incubation buffer for 4 h at 
room temperature, followed by 1 h incubation with avidin-biotin 
complex (Vectastain ABC Elite kit, Vector Laboratories) in TBS. 
After the completion of antiserum reaction procedures, sections 
were visualized with 0.03% diaminobenzidine, 0.15% NiNH4SO4, 
and 0.003% hydrogen peroxide in TBS.
All sections were mounted in gelatin-coated slides, air-dried 
and dehydrated through ascending alcohol series, which were 
cleared with xylene, and cover slipped with Permount (Fisher 
Scientific, USA). To verify the specificity of the immunohisto-
chemical procedures, we included negative controls in which the 
primary antiserums were omitted from the staining procedure. In 
these conditions, neither cells nor fibers were stained.
The seven sections containing the DRN [Bregma −4.24 to 
−5.20 mm (15)] were obtained and photographed at 40× magnifi-
cation with a digital camera mounted on an Olympus microscope 
(DP21, Olympus, Japan). To verify successful infusion of shRNA 
in the DRN, the distribution of GFP immunoreactive cells was 
evaluated on these seven sections.
statistics
Lordosis quotients in the Control and βERKD groups were ana-
lyzed by a three-way analysis of variance (ANOVA) for repeated 
measurements for the main effects of vector treatment, day, week, 
and their interactions. LQs in the missed βERKD group were 
analyzed by a two-way ANOVA for repeated measurement for 
the main effect of day and week, and their interactions. ANOVAs 
were followed by Bonferroni post hoc test when it was appropri-
ate. Lordosis Quality Scores were analyzed and compared by 
Mann–Whitney U test between day 1 and day 2 in each week 
in each vector treatment group. All data were presented as 
mean ± SEM. Statistically significant differences were considered 
at p < 0.05 (two-tailed). LQs were analyzed using SPSS 21.0 (SPSS 
Inc., Chicago, IL, USA) statistical package, and Lordosis Quality 
Scores were analyzed using StatView 5.0.1 (SAS Institute Inc., 
Cary, NC, USA).
resUlTs
Verification of Transfection
Similar to previous reports in the medial amygdala and medial 
preoptic area (16), the efficacy of the vector in silencing the 
expression of ERβ site-specifically in the DRN was confirmed as 
shown in Figure 2.
Successful infusion of shRNA in the DRN was confirmed in 12 
females injected with AAV-shLUC (Control) and 10 females with 
AAV-shERβ (βERKD) (Figure 3). In addition to these mice in 
FigUre 4 | Comparison of distribution pattern of adeno-associated virus 
within the mediodorsal area of dorsal part of the dorsal raphe nucleus 
(Bregma −4.72 mm) determined by green fluorescent protein 
immunohistochemistry in successful ERβ knockdown (βERKD) (left) and 
missed βERKD (middle and right) mice. The scale bar represents 200 µm.
FigUre 3 | Representative distribution pattern of adeno-associated virus 
within the dorsal raphe nucleus determined based on green fluorescent 
protein immunohistochemistry. The scale bar represents 200 µm.
FigUre 2 | Representative photomicrographs of immunohistochemically 
labeled cells for green fluorescent protein (GFP) in brain sections of control 
and ERβ knockdown (βERKD) groups (top panels), and those for estrogen 
receptor (ER) β in the adjacent sections (bottom panels). GFP and ERβ 
immunoreactive cells were detected by the methods described in the present 
and previous studies (16). The scale bar in the panel represents 100 µm. 
Arrows in the top panels indicate GFP stained cells, and arrow heads in the 
bottom panel indicate ERβ stained cells.
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which AAV-shERβ was successfully infused into the entire DRN, 
there were five females in which AAV-shERβ was not spread in 
the mediodorsal area of dorsal part of the nucleus (Figure  4). 
These animals were classified as a missed βERKD group, and 
their behavioral data were analyzed separately. The mediodorsal 
area of dorsal part of the DRN was defined as the area within a 
0.2 mm diameter circle placed on right below the bottom edge of 
the aqueduct and ranging from Bregma −4.48 to −4.84 mm (15) 
(Figure 4).
effect of erβ Knockdown in the Drn on 
the lQ
Knocking down of ERβ in the DRN dramatically affected LQ 
in day 2, but not in day 1. As shown in Figure 5, Control and 
βERKD showed similar levels of LQ on day 1 test in each week. 
In the Control group, the LQs were greatly decreased on day 2 
compared with day 1 in all three weekly tests, whereas βERKD 
showed similar levels of LQ on day 2 as those on day 1 in all 
three tests. Three-way repeated measures ANOVA revealed sig-
nificant effects of Day [F(1, 20) = 22.247, P < 0.0001], Treatment 
[F(1, 20) =  4.881, P <  0.05], and Week [F(2, 40) =  37.487, 
P  <  0.0001]. There were significant interactions between 
Treatment and Day [F(1, 20) = 5.518, P < 0.05], Treatment and 
Week [F(2, 40) = 3.876, P < 0.05]. There were no statistically 
significant interactions between Day and Week [F(2, 40) = 0.390, 
ns] or Treatment, Day, and Week [F(2, 40) =  0.381, ns]. Post 
hoc analysis revealed that LQ on day 2 was lower than day 1 
in the Control group alone (the day 1 vs. the day 2 in each 
test, P < 0.01, for control) in each test. However, there was no 
significant difference between day 1 and day 2 in LQ of βERKD 
in each test.
FigUre 5 | Effect of estrogen receptor (ER) β knockdown in the dorsal raphe nucleus on Lordosis quotient (LQ). LQ of control (left) and ERβ knockdown (βERKD) 
(right) in each test. *P < 0.05 vs. day 1. Data presented as mean ± SEM.
FigUre 6 | Lordosis Quality Score of control (left) and ERβ knockouts (right) mice in each test. There was no difference between day 1 and day 2 in each week 
regardless of treatment group. The number in parentheses showed the number of mice which expressed lordosis (i.e., lordosis score of higher than 1) in each test.
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effect of erβ Knockdown in the Drn on 
the lordosis Quality score
Estrogen receptor β knockdown did not affect the Lordosis Quality 
Score (Figure 6). Mann–Whitney U test revealed that there was 
no difference between day 1 and day 2 of Lordosis Quality Score 
in each week regardless of treatment group (Control: Week 1; 
U = 44.000, Week 2; U = 40.500, Week 3; U = 33.500, βERKD: 
Week 1; U = 16.000, Week 2; U = 43.000, Week 3; U = 33.000, 
all ns).
lQ of Missed βerKD group
Behavioral data shown above included only mice in which the 
range of vector infusion covered the entire targeted area, but 
not elsewhere. These βERKD mice maintained the LQ that was 
equivalent to day 1 in day 2. On the other hand, such effect was 
absent if the virus did not spread into the mediodorsal area of 
dorsal part in the DRN. Two-way repeated measures ANOVA 
revealed significant effects of Day [F(1, 4) = 21.574, P < 0.05] and 
Week [F(2, 8) = 7.704, P < 0.05]. There were no statistically sig-
nificant interactions between Day and Week [F(2, 8) = 0.141, ns].
DiscUssiOn
In this study, we demonstrated that knocking down of ERβ in the 
DRN altered female sexual behavior on the day after behavioral 
estrus without affecting the behavior on the day of behavioral 
estrus. Our results showed that LQ between βERKD and Control 
mice was at a similar level on day 1 test performed at 44–46 h 
after EB and 4–6  h after progesterone injection that mimicked 
hormonal states of the day of behavioral estrus. By contrast, on 
day 2 test which corresponds to the day after behavioral estrus, 
βERKD mice still showed similar levels of LQ in comparison with 
their LQ on day 1 in each of three test. Control mice showed 
greatly decreased levels of LQ on day 2 compared with day 1 
(Figure  5). These findings are consistent with previous studies 
using βERKO mice in which both gonadally intact and hormo-
nally manipulated ovariectomized βERKO females continuously 
showed elevated levels of receptivity on the day after behavioral 
estrus [(4); unpublished data]. Thus, our finding suggests that the 
DRN is one of the brain sites responsible for the ERβ-mediated 
inhibitory regulation of female sexual behavioral expression 
on the day after behavioral estrus. On the other hand, Lordosis 
FigUre 7 | Lordosis quotient of missed ERβ knockdown (βERKD) mice. 
Data presented as mean ± SEM.
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Quality Score that indicates the quality of each lordosis was not 
different between day 1 and day 2 in both βERKD and Control 
groups (Figure 6). The brain sites responsible for the qualitative 
aspect of lordosis posture and possible involvement of gonadal 
steroids are not known. Our data indicate that ERβ expressed 
in the DRN may not be involved in the qualitative regulation of 
lordosis responses.
Furthermore, the knockdown effect was absent if the virus 
did not spread into the mediodorsal area within the dorsal part 
of the DRN even though the infusion was successful elsewhere 
within the nucleus (Figures 4 and 7). This finding may indicate 
that even within the DRN, the mediodorsal area of dorsal part is 
the most critical area for the ERβ-mediated inhibition of female 
sexual behavior on the day after behavioral estrus.
The exact mechanism of this ERβ-mediated inhibitory 
regulation of female sexual behavior has yet to be elucidated. 
However, it is possible to hypothesize that ERβ in the DRN 
may be involved in inhibition of female sexual behavior by 
intervening the serotonergic systems. Serotonin is known to act 
inhibitory on the expression of female sexual behavior through 
its binding to 5HT-1A receptors (17). The DRN is the largest 
serotonin synthesizing nucleus whose projections directly 
innervate the VMN and MPOA where 5HT-1A receptors are 
highly abundant (18–20). Selective lesions of serotonergic neu-
rons projecting from the DRN to the VMN have been reported 
to facilitate lordosis (21). On the other hand, site-specific activa-
tion of 5HT-1A receptors either in the VMN or MPOA by local 
infusion of selective agonist, 8-hydroxy-2-(di-n-propylamino)
tetralin (8-OH-DPAT) reduces the expression of lordosis in 
hormonally primed ovariectomized and gonadally intact proes-
trus female rats (22–24). Within the DRN, more than 95% of 
ERβ expressing neurons are serotonergic (14), and the majority 
of serotonergic neurons that project into the MPOA express 
ERβ (25). Furthermore, the administration of 17β-estradiol or 
ERβ-specific agonists, DPN to ovariectomized female rats are 
reported to enhance mRNA expression of tryptophan hydroxy-
lase 2 (TPH 2), the rate-limiting enzyme for serotonin synthesis 
(26). In addition, the TPH 2 mRNA expression is greatly reduced 
in the DRN of βERKO female mice (14). Thus, ERβ in the DRN 
is possibly mediating the inhibition of female sexual behavior 
by upregulating the activity of the serotonergic system within 
the DRN that further activates 5HT-1A receptors expressed 
in hypothalamic regions such as the VMN and MPOA. The 
expression of 5HT-1A receptors in these regions seems to be also 
upregulated by estrogen (20, 27). Interestingly, a recent study by 
Spiteri et al. (28) reported that the site-specific knockdown of 
ERα in the MPOA, the region also known for its inhibitory role 
on the expression of female sexual behavior, increase the lordosis 
expression in response to a low dose EB treatment that generally 
fails to stimulate lordosis in ovariectomized females. Thus, the 
inhibitory action of the MPOA on the female sexual behavior 
seems to be ERα mediate although the crucial role of ERα in the 
VMN in the facilitation of the behavior is well known (7).
Collectively with these studies, our present findings provide 
a significant piece to lay out the possible mechanism underling 
the cyclic regulation of female sexual behavior. Thus, on the day 
of behavioral estrus, high levels of circulating estradiol simul-
taneously (1) facilitate behavioral expression via ERα-mediated 
genomic action in the VMN, (2) upregulate 5HT-1A receptor 
expression via ERα in the hypothalamic areas such as the VMN 
and MPOA, while (3) upregulate TPH 2, the rate-limiting enzyme 
for serotonin synthesis in the DRN via ERβ. On the day after 
behavioral estrus, serotonin release by serotonergic neurons in 
the DRN may activate 5HT-1A receptors in the VMN and/or the 
MPOA and inhibit lordosis expression.
In addition to serotonin, progesterone is also known to inhibit 
the expression of female sexual behavior in its long-term effect 
while its short-term effect is facilitatory. Progesterone acts through 
progesterone receptor (PR), and the expression of the receptor is 
highly dependent on estrogen action. In female mice, the expres-
sion of PR in the VMN is known to be upregulated by estrogen via 
ERα (7). Whereas in the DRN, it seems to be ERβ dependent since 
EB administration still upregulate PR expression in the DRN of 
ovariectomized αERKO female mice (29). Moreover, estrogen-
induced PR expression in the DRN found in αERKO female is 
suspected to be on the serotonergic neuron since the majority of 
PR immunoreactive cells coexpressed TPH immunoreactivity in 
these females (29). Therefore, it is reasonable to hypothesize that 
PR upregulation by E2 in the DRN is mediated ERβ by and this 
progesterone–PR signaling pathway, in turn, may contribute the 
activation of serotonergic system that inhibits the expression of 
female sexual behavior on the day after behavioral estrus.
In this study, we focused on lordosis that reflects more 
of consummatory aspects. However, we cannot exclude the 
possible effect of ERβ knockdown in the DRN on behavio-
ral components other than lordosis itself. Ogawa et  al. (4) 
reported that gonadally intact βERKO female mice exhibited 
slightly higher levels of proceptivity throughout the estrous 
cycle compared with WT mice. Thus, in future experiments, 
it will be important to investigate the site-specific involvement 
of ERβ in the DRN in the appetitive aspects of female sexual 
behavior. It is also important to directly monitor or manipulate 
neuronal activity of ERβ- and/or PR-expressing cells and the 
serotonergic system within the DRN during both estrus and 
non-estrus phase to further elucidate neuronal and intracellular 
mechanisms of ERβ-mediated inhibitory regulation of female 
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sexual behavior. Moreover, it is our great interest to investigate 
site-specific involvement of ERβ in brain regions other than 
the DRN such as the MPOA, the region also involved in the 
inhibitory regulation of female sexual behavior and known to 
highly express ERβ.
cOnclUsiOn
The main aim for this study was to elucidate site-specific involve-
ment of ERβ expressed in the DRN in the inhibitory regulation 
of sexual behavior in female mice. This study demonstrated that 
βERKD mice continuously showed elevated levels of receptivity 
even on the day after behavioral estrus, whereas control mice 
showed greatly reduced receptivity on the day after behavioral 
estrus compared with the day of estrus. Therefore, the findings 
in this study suggest that ERβ in the DRN may be involved in the 
inhibition of female sexual behavior on the day after behavioral 
estrus. This is the first study to demonstrate the site-specific 
involvement of ERβ in the inhibitory regulation of female sexual 
behavior.
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